SCHEMBL6070313

SCHEMBL6070313

O=C1CCCc2c1[nH]c1cccc(C(=O)O)c21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
PARP1 P09874 4/20 0.51
KDM4E B2RXH2 5/20 0.46
GFER P55789 1/20 0.46
PBRM1 Q86U86 2/20 0.43
LMNA P02545 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.38
POLB P06746 1/20 0.38
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
FABP4 P15090 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6238374 0.79 PARP1 (0.59) MEN1KMT2APARP1KDM4EHPGD
SCHEMBL20601979 0.78 KDM4E (0.64) HSD17B10MEN1KMT2APARP1KDM4E
SCHEMBL2485381 0.78 GFER (0.60) HSD17B10MEN1KMT2APARP1KDM4E
SCHEMBL15069471 0.77 GFER (0.52) HSD17B10MEN1KMT2APARP1KDM4E
SCHEMBL6070839 0.76 PARP1 (0.47) HSD17B10MEN1KMT2APARP1KDM4E
SCHEMBL6070845 0.76 PARP1 (0.47) HSD17B10MEN1KMT2APARP1KDM4E
SCHEMBL6626963 0.74 GFER (0.52) HSD17B10MEN1KMT2APARP1KDM4E
SCHEMBL1759573 0.72 MRGPRX4 (0.51) HSD17B10KDM4EGFERLMNAALDH1A1
SCHEMBL4021839 0.72 HSD17B10 (1.00) HSD17B10MEN1KMT2APARP1KDM4E
SCHEMBL29666273 0.72 HSD17B10 (1.00) HSD17B10MEN1KMT2APARP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264493-A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K1, MAP3K19, MAP3K20 HSD17B10 4387/4885MEN1 2523/4885KMT2A 2104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.